NASDAQ:CDIO Cardio Diagnostics (CDIO) Stock Price, News & Analysis → This consistently signaled gains of 453%... 610%... and even 1036%... (From Insiders Exposed) (Ad) Free CDIO Stock Alerts $1.37 +0.02 (+1.48%) (As of 03/27/2024 ET) Add Compare Share Share Today's Range$1.29▼$1.4050-Day Range$1.24▼$2.3252-Week Range$0.17▼$4.19Volume118,452 shsAverage Volume427,034 shsMarket Capitalization$28.14 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Get Cardio Diagnostics alerts: Email Address Cardio Diagnostics MarketRank™ Stock AnalysisAnalyst RatingN/AUpside/DownsideN/AShort InterestHealthy2.73% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment1.44Based on 2 Articles This WeekInsider TradingN/AProj. Earnings GrowthGrowingFrom ($0.75) to ($0.55) Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.1.47 out of 5 starsMedical Sector892nd out of 939 stocksDiagnostic Substances Industry13th out of 13 stocks N/A Analyst's Opinion Consensus RatingThere is not enough analysis data for Cardio Diagnostics. Previous Next 5.0 Short Interest Percentage of Shares Shorted2.73% of the float of Cardio Diagnostics has been sold short.Short Interest Ratio / Days to CoverCardio Diagnostics has a short interest ratio ("days to cover") of 0.4, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Cardio Diagnostics has recently decreased by 7.69%, indicating that investor sentiment is improving significantly. Previous Next 0.0 Dividend Strength Dividend YieldCardio Diagnostics does not currently pay a dividend.Dividend GrowthCardio Diagnostics does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for CDIO. Previous Next 3.6 News and Social Media Coverage News SentimentCardio Diagnostics has a news sentiment score of 1.44. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.61 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 2 news articles for Cardio Diagnostics this week, compared to 1 article on an average week.Search InterestOnly 18 people have searched for CDIO on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.MarketBeat Follows4 people have added Cardio Diagnostics to their MarketBeat watchlist in the last 30 days. This is an increase of 100% compared to the previous 30 days. Previous Next 1.7 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Cardio Diagnostics insiders have not sold or bought any company stock.Percentage Held by Insiders30.00% of the stock of Cardio Diagnostics is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 8.06% of the stock of Cardio Diagnostics is held by institutions. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for Cardio Diagnostics are expected to grow in the coming year, from ($0.75) to ($0.55) per share.Price to Book Value per Share RatioCardio Diagnostics has a P/B Ratio of 3.04. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here Ad Huge AlertsTrending Stocks Sent To You In Real Time Sign up today and get instant access to our next stock alert! You do not want to miss out on this next pick! Our stock picks have been known to soar! Click To Get Our Next Alert About Cardio Diagnostics Stock (NASDAQ:CDIO)Cardio Diagnostics Holdings, Inc., an artificial intelligence-powered precision cardiovascular medicine company, develops and commercializes epigenetics-based clinical tests for cardiovascular disease. It offers Epi+Gen CHD, a three-year symptomatic coronary heart disease (CHD) risk assessment test targeting CHD events, including heart attacks; and PrecisionCHD, an integrated epigenetic-genetic blood test for the early detection of coronary heart disease. The company was founded in 2017 and is headquartered in Chicago, Illinois.Read More CDIO Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart CDIO Stock News HeadlinesMarch 18, 2024 | msn.comPotential novel biomarkers of coronary heart disease discoveredMarch 14, 2024 | finance.yahoo.comCardio Diagnostics Holdings, Inc. to Showcase HeartRisk and Actionable Clinical Intelligence Version 3 at the American College of Cardiology’s 73rd Annual Scientific SessionMarch 28, 2024 | Crypto 101 Media (Ad)SHOCKING Crypto Leak…A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. March 14, 2024 | businesswire.comCardio Diagnostics Holdings, Inc. to Showcase HeartRisk and Actionable Clinical Intelligence Version 3 at the American College of Cardiology's 73rd Annual Scientific SessionMarch 6, 2024 | morningstar.comCardio Diagnostics Holdings IncMarch 5, 2024 | msn.comStudy finds coronary artery calcium score is predictive of heart attacks, strokesMarch 5, 2024 | finance.yahoo.comCardio Diagnostics Holdings, Inc. Announces Issuance of Second U.S. Patent for Compositions and Methods for Detecting Predisposition to Cardiovascular DiseaseFebruary 18, 2024 | investing.comCardio Diagnostics expands HeartRisk platform nationwideMarch 28, 2024 | Behind the Markets (Ad)The AI Defense Stock Set to SoarTo protect our interests, The Pentagon has partnered with this small AI defense contractor - creating some of the most powerful AI defenses ever made.February 15, 2024 | stockhouse.comCardio Diagnostics Holdings, Inc. Expands HeartRisk(TM) Platform Offering to Diverse Markets in Conjunction with Nationwide RolloutFebruary 15, 2024 | finance.yahoo.comCardio Diagnostics Holdings, Inc. Expands HeartRisk™ Platform Offering to Diverse Markets in Conjunction with Nationwide RolloutFebruary 15, 2024 | businesswire.comCardio Diagnostics Holdings, Inc. Expands HeartRisk™ Platform Offering to Diverse Markets in Conjunction with Nationwide RolloutFebruary 10, 2024 | msn.comCardiovascular disease is the leading cause of death in the Valley. Augusta Health wants to change that.February 7, 2024 | finance.yahoo.comCardio Diagnostics Holdings, Inc. Expands Partnership with Family Medicine Specialists to Bring Its Specialty Cardiology Tests to Select Walmart SupercentersFebruary 5, 2024 | finance.yahoo.comHouston-Based resTOR Longevity Clinic to Offer Cardio Diagnostics' AI-Driven Epigenetic-Genetic Heart Disease TestsJanuary 31, 2024 | seekingalpha.comDermTech to lay off 30 more workers as it focuses on melanoma testJanuary 26, 2024 | msn.comCardio Diagnostics files for $17M mixed shelfJanuary 24, 2024 | finance.yahoo.comCardio Diagnostics Holdings, Inc. Accelerates Cardiac Care Innovation with Appointment of Dr. Vimal Ramjee as Strategic AdvisorJanuary 8, 2024 | finance.yahoo.comCardio Diagnostics Holdings, Inc. Announces the Grant of a Patent in IndiaJanuary 4, 2024 | businesswire.comCardio Diagnostics Holdings, Inc. Unveils Groundbreaking Employer Cardiovascular Disease Risk Intelligence Platform, HeartRisk™January 4, 2024 | finance.yahoo.comCORRECTING and REPLACING Cardio Diagnostics Holdings, Inc. Unveils Groundbreaking Employer Cardiovascular Disease Risk Intelligence Platform, HeartRisk™January 3, 2024 | businesswire.comAmerican Medical Association (AMA) Grants Cardio Diagnostics a Dedicated CPT PLA Reimbursement Code for Epi+Gen CHD, an AI-powered Test for Assessing the Probability of a Heart ...January 3, 2024 | finance.yahoo.comAmerican Medical Association (AMA) Grants Cardio Diagnostics a Dedicated CPT PLA Reimbursement Code for Epi+Gen CHD, an AI-powered Test for Assessing the Probability of a Heart Attack or Coronary Heart Disease EventJanuary 2, 2024 | msn.comCardio Climbs on AMA NodJanuary 2, 2024 | marketwatch.comCardio Diagnostics Shares Rise 22% After Reimbursement Code for PrecisionCHDJanuary 2, 2024 | benzinga.comWhy Cardio Diagnostics Holdings Stock Is Racing HigherJanuary 2, 2024 | businesswire.comAmerican Medical Association (AMA) Grants Cardio Diagnostics Holdings, Inc.’s AI-Powered Coronary Heart Disease Detection Test, PrecisionCHD, a Dedicated CPT PLA ...See More Headlines Receive CDIO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Cardio Diagnostics and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today3/28/2024Next Earnings (Estimated)4/01/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Diagnostic substances Sub-IndustryN/A Current SymbolNASDAQ:CDIO CUSIPN/A CIK1870144 Webcardiodiagnosticsinc.com Phone302-281-2147FaxN/AEmployees7Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-4,660,000.00 Net MarginsN/A Pretax Margin-73,893.48% Return on Equity-293.45% Return on Assets-137.77% Debt Debt-to-Equity RatioN/A Current Ratio1.53 Quick Ratio1.53 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value$0.45 per share Price / Book3.04Miscellaneous Outstanding Shares20,540,000Free Float14,378,000Market Cap$28.14 million OptionableNot Optionable Beta5.16 Beginner's Guide to Pot Stock InvestingClick the link below and we'll send you MarketBeat's guide to pot stock investing and which pot companies show the most promise. Get This Free Report Key ExecutivesDr. Meeshanthini V. Dogan Ph.D. (Age 35)Co-Founder, CEO & Director Comp: $433.9kMs. Elisa Michael Luqman Esq. (Age 60)J.D., M.B.A., Chief Financial Officer Comp: $175.83kDr. Robert A. Philibert M.D. (Age 62)Ph.D., Co-Founder, Chief Medical Officer & Director Mr. Timur Dogan Ph.D. (Age 36)Chief Technology Officer Ms. Khullani Abdullahi J.D. (Age 40)Vice President of Revenue & Strategy Key CompetitorsArisz AcquisitionNASDAQ:ARIZOncoCyteNASDAQ:OCXARCA biopharmaNASDAQ:ABIOMountain Crest Acquisition Corp. VNASDAQ:MCAGMicroAlgoNASDAQ:MLGOView All CompetitorsInsiders & InstitutionsVanguard Group Inc.Bought 168,117 shares on 3/11/2024Ownership: 1.130%Vanguard Group Inc.Bought 168,117 shares on 2/15/2024Ownership: 1.130%Northern Trust CorpBought 46,106 shares on 2/13/2024Ownership: 0.224%Vontobel Holding Ltd.Bought 12,000 shares on 1/30/2024Ownership: 0.058%Meeshanthini DoganBought 16,481 shares on 8/31/2023Total: $9,064.55 ($0.55/share)View All Insider TransactionsView All Institutional Transactions CDIO Stock Analysis - Frequently Asked Questions Should I buy or sell Cardio Diagnostics stock right now? 1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Cardio Diagnostics in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" CDIO shares. View CDIO analyst ratings or view top-rated stocks. How have CDIO shares performed in 2024? Cardio Diagnostics' stock was trading at $2.49 at the beginning of the year. Since then, CDIO shares have decreased by 45.0% and is now trading at $1.37. View the best growth stocks for 2024 here. Are investors shorting Cardio Diagnostics? Cardio Diagnostics saw a decrease in short interest in the month of March. As of March 15th, there was short interest totaling 456,300 shares, a decrease of 7.7% from the February 29th total of 494,300 shares. Based on an average daily volume of 1,230,000 shares, the short-interest ratio is currently 0.4 days. Currently, 2.7% of the shares of the stock are sold short. View Cardio Diagnostics' Short Interest. When is Cardio Diagnostics' next earnings date? The company is scheduled to release its next quarterly earnings announcement on Monday, April 1st 2024. View our CDIO earnings forecast. Who are Cardio Diagnostics' major shareholders? Cardio Diagnostics' stock is owned by a number of retail and institutional investors. Top institutional shareholders include Vanguard Group Inc. (1.13%), Vanguard Group Inc. (1.13%), Northern Trust Corp (0.22%) and Vontobel Holding Ltd. (0.06%). Insiders that own company stock include Meeshanthini Dogan and Robert Philibert. View institutional ownership trends. How do I buy shares of Cardio Diagnostics? Shares of CDIO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:CDIO) was last updated on 3/28/2024 by MarketBeat.com Staff From Our PartnersTop Project Outperforms BTC in 2023…Crypto 101 MediaMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading Academy“The Stock Market’s Bull Run is Far from Over” -BarronsVertical Research AdvisorySHOCKING Footage From Tesla Gigafactory In Austin, TexasInvestorPlaceBuy this small stock before coming AI Tidal WaveChaikin AnalyticsThe 3rd Revolution in WarfareWeiss RatingsDid You Get Your Free Bitcoin Yet?Crypto Swap Profits Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cardio Diagnostics Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.